Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Looked at Q3 filing on Sedar again

<< Previous

Bullboard Posts

Next >>

Comment by N0taP00pon Apr 13, 2023 10:31pm

193 Views

Post# 35394451

RE:RE:RE:Looked at Q3 filing on Sedar again

Infinity, pretty much a universal consensus on that on this board. On the surface, it looks like an arrogant "don't care" attitude. But the sheer duration of the news gap with no meaningful updates (see all the potential topics consultant99 mentioned before) has me hoping that this time it is the real deal. If not, it's back to being entertained by SF and the Sunshine Band. GLTY.

<< Previous

Bullboard Posts

Next >>

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles